Quick Take
ACell (ACLL) has filed to raise $86.25 million in an IPO of its common stock, according to an S-1 registration statement.
The firm develops and sells various wound care products for post-surgical applications.
ACLL has experienced a drop in sales as the Covid-19 pandemic has reduced elective surgeries.
Company & Technology
Columbia, Maryland-based ACell was founded to develop proprietary porcine urinary bladder matrix technologies to assist in the reinforcement of soft tissue that has been damaged.
Management is headed by Mr. Patrick McBrayer, who has been with the firm since